BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10635451)

  • 21. Synthesis, antifungal activity, and structure-activity relationships of coruscanone A analogues.
    Babu KS; Li XC; Jacob MR; Zhang Q; Khan SI; Ferreira D; Clark AM
    J Med Chem; 2006 Dec; 49(26):7877-86. PubMed ID: 17181171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of novel 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[(4-substitutedphenyl)-piperazin-1-yl]-propan-2-ols as antifungal agents.
    Sun QY; Zhang WN; Xu JM; Cao YB; Wu QY; Zhang DZ; Liu CM; Yu SC; Jiang YY
    Eur J Med Chem; 2007 Aug; 42(8):1151-7. PubMed ID: 17184885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbon analogs of antifungal dioxane-triazole derivatives: synthesis and in vitro activities.
    Uchida T; Somada A; Kagoshima Y; Konosu T; Oida S
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6538-41. PubMed ID: 18974000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and evaluation of novel quinazoline-2,4-dione derivatives as chitin synthase inhibitors and antifungal agents.
    Ji Q; Yang D; Wang X; Chen C; Deng Q; Ge Z; Yuan L; Yang X; Liao F
    Bioorg Med Chem; 2014 Jul; 22(13):3405-13. PubMed ID: 24856180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of novel pyrrolidinyl sordaricin derivatives as antifungal agents.
    Arai M; Harasaki T; Fukuoka T; Kaneko S; Konosu T
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2733-6. PubMed ID: 12217365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antifungal activity of sertaconazole.
    Drouhet E; Dupont B
    Arzneimittelforschung; 1992 May; 42(5A):705-10. PubMed ID: 1627187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, structure, and antifungal evaluation of some novel 1,2,4-triazolylmercaptoacetylthiosemicarbazide and 1,2,4-triazolylmercaptomethyl-1,3,4-thiadiazole analogs.
    Klip NT; Capan G; Gürsoy A; Uzun M; Satana D
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):126-31. PubMed ID: 20030516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based design, synthesis, and antifungal activity of new triazole derivatives.
    Sheng C; Che X; Wang W; Wang S; Cao Y; Yao J; Miao Z; Zhang W
    Chem Biol Drug Des; 2011 Aug; 78(2):309-13. PubMed ID: 21585708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and biological evaluation of novel diazaspirodecanone derivatives containing piperidine-4-carboxamide as chitin synthase inhibitors and antifungal agents.
    Ji Q; Li B; Chu Y; Wu H; Du C; Xu Y; Shen Y; Deng J
    Bioorg Chem; 2021 Sep; 114():105108. PubMed ID: 34175721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo antifungal activities of aminopiperidine derivatives, novel ergosterol synthesis inhibitors.
    Hata M; Yoshida K; Ishii C; Otani T; Ando A
    Biol Pharm Bull; 2010; 33(3):473-6. PubMed ID: 20190412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.
    Xu J; Cao Y; Zhang J; Yu S; Zou Y; Chai X; Wu Q; Zhang D; Jiang Y; Sun Q
    Eur J Med Chem; 2011 Jul; 46(7):3142-8. PubMed ID: 21420761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro antifungal activity of novel azole derivatives with a morpholine ring, UR-9746 and UR-9751, and comparison with fluconazole.
    Stevens DA; Aristizabal BH
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):103-6. PubMed ID: 9368086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Synthesis and antifungal activity of 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted-2-propanols].
    Zhang DZ; Zhou TS; Wu YJ; Liu CM; Ma MC; Feng XT
    Yao Xue Xue Bao; 1997 Dec; 32(12):943-9. PubMed ID: 11596195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and molecular docking studies of novel triazole as antifungal agent.
    Chai X; Zhang J; Cao Y; Zou Y; Wu Q; Zhang D; Jiang Y; Sun Q
    Eur J Med Chem; 2011 Jul; 46(7):3167-76. PubMed ID: 21531485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial evaluation of some Mannich bases of acetophenones and representative quaternary derivatives.
    Gul HI; Denizci AA; Erciyas E
    Arzneimittelforschung; 2002; 52(10):773-7. PubMed ID: 12442641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antifungal activity of 2/3-arylthio- and 2,3-bis(arylthio)-5-hydroxy-/5-methoxy-1,4-naphthoquinones.
    Ryu CK; Shim JY; Chae MJ; Choi IH; Han JY; Jung OJ; Lee JY; Jeong SH
    Eur J Med Chem; 2005 May; 40(5):438-44. PubMed ID: 15893017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
    Wildfeuer A; Seidl HP; Paule I; Haberreiter A
    Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antifungal activity of the novel triazole derivatives containing 1,2,3-triazole fragment.
    Yu S; Wang N; Chai X; Wang B; Cui H; Zhao Q; Zou Y; Sun Q; Meng Q; Wu Q
    Arch Pharm Res; 2013 Oct; 36(10):1215-22. PubMed ID: 23640383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.